Document is current
Any future updates will be listed below
-
Authors
Autio, Karen A. https://orcid.org/0000-0003-0720-0390
Kyriakopoulos, Christos E.
Palyca, Paul
Xiao, Han
Emamekhoo, Hamid
Danila, Daniel
Jan, Mehrin
Catharine, Victoria
Riedel, Elyn
Devitt, Michael
Laird, A. Douglas
Scher, Howard I.
-
Funding
Funding for this research was provided by:
Pfizer Foundation
NIH
- License Information
-
More Information
Article History
Received: 11 August 2025
Accepted: 20 August 2025
First Online: 4 September 2025
Declarations
:
: Financial interests: Paul Palyca, Han Xiao, Mehrin Jan, Victoria Catharine, Elyn Riedel, and Michael Devitt declare they have no financial interests. Karen Autio has received research support (to institution) from Amgen, Pfizer, Johnson and Johnson, Janux Therapeutics, Astra Zeneca, Parker Institute for Cancer Immunotherapy. Karen Autio reports compensated consultant for VIR Biotech and honoraria from MashUp Media. Christos Kyriakopoulos has received research support (to institution) from Sanofi-Aventis, Gilead Sciences, Incyte Corporation, ESSA Pharma, Pionyr Immunopharma, AstraZeneca, Merck, BMS, Regeneron, Madison Vaccines, and EMD Serono. Christos Kyriakopoulos owns stock from EPIC Systems and Biogen. Daniel Danila has received research support from the US Department of Defense, American Society of Clinical Oncology, Prostate Cancer Foundation, Stand Up 2 Cancer, Amgen, Janssen Research & Development, Astellas, Medivation, Agensys, Genentech, and CreaTV. A. Douglas Laird is an employee of Pfizer and may hold Pfizer stock/stock options. Howard Scher reports compensated consultant/advisor to Bayer, Pfizer Inc, Novartis, Regeneron Pharmaceuticals, Sanofi (Genzyme Corporation) WCG Oncology and research funding (to his institution) from AIQ Solutions, Astrin, Biodesix, Epic Sciences, Janssen, Prostate Cancer Foundation and ThermoFisher. Non-financial interests: Christos Kyriakopoulos has served on advisory board for Sanofi-Aventis, Exelixis, EMD Serono, Pfizer, AVEO pharmaceuticals, and Janssen. Hamid Emamekhoo has served as an advisory board consultant for BMS, Eisai, and Cardinal Health within the last 24 months. Daniel Danila has served as a consultant for Janssen Research & Development, AstraZeneca, BioView LTD, Clovis, Astellas, Medivation, Sanador, Angle LLT, Pfizer, Agensys, Merck, and Amgen. Howard Scher reports uncompensated consultant/advisory to AIQ Global Inc. Amgen and Janssen Research & Development, LLC, Janssen Biotech, Inc, Promontory Therapeutics; Honorarium Arsenal Capital, Physician Education Resource and non-financial support from Amgen, Astrin Biosciences, Bayer, Biodesix, Epic Sciences, Promontory Therapeutics, Pfizer Inc, Prostate Cancer Foundation, and WCG Oncology.
